NCT02009631View on ClinicalTrials.gov

A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Breast CancerOvarian CancerColon CancerLung CancerGastric CancerSolid Tumors
Interventions
DRUG

Veliparib (ABT-888)

DRUG

Placebo

Trial Locations (5)

28050

Site Reference ID/Investigator# 117517, Madrid

78229

Site Reference ID/Investigator# 116016, San Antonio

85258

Site Reference ID/Investigator# 116015, Scottsdale

9713 GZ

Site Reference ID/Investigator# 117320, Groningn

6229 HX

Site Reference ID/Investigator# 117336, Maastricht

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY